Status:
COMPLETED
To Reach Unrestricted Services for Transgender Women
Lead Sponsor:
University of Central Florida
Collaborating Sponsors:
Florida International University
Conditions:
Transgender Women
Substance Abuse
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Florida has the fifth largest transgender population in the United States. Transgender women, particularly those of color, in the southern part of Florida are a marginalized population who are impacte...
Detailed Description
Background: Transgender women are disproportionally affected by substance abuse and HIV. Evidence-based interventions that can address both issues simultaneously may efficiently improve the overall he...
Eligibility Criteria
Inclusion
- Transgender woman over the age of 18
- HIV uninfected
- no current substance abuse use according to AUDIT and SBIRT criteria
Exclusion
- HIV infected transgender woman
- evidence of hazardous alcohol or illicit drug use
Key Trial Info
Start Date :
September 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2024
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT03877497
Start Date
September 19 2019
End Date
December 4 2024
Last Update
December 10 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida International University
Miami, Florida, United States, 33199
2
University of Central Florida
Orlando, Florida, United States, 32827